Amneal to Report First Quarter 2026 Results on May 1, 2026
Amneal (NASDAQ: AMRX) will release its first quarter 2026 financial results on Friday, May 1, 2026 before market open.
Rhea-AI Summary
Amneal (NASDAQ: AMRX) will release its first quarter 2026 financial results on Friday, May 1, 2026 before market open. The company will host a live audio webcast at 8:30 a.m. ET, accessible via the Investor Relations site, with a conference line and replay posted after the call.
Dial-in details and the access code 458312872 are provided for conference access; registration is available on the Investor Relations website.
Positive
- None.
Negative
- None.
Details
News Market Reaction – AMRX
In the Apr 8 session, AMRX gained 3.17%, reflecting a moderate positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
- Earnings date
- May 1, 2026
- First quarter 2026 results release before market open
- Webcast time
- 8:30 a.m. ET
- Audio webcast for Q1 2026 results
- US dial-in number
- 1 (833) 461-5787
- Conference line access for earnings call
- Access code
- 458312872
- Conference call access code for participants
- 2025 net revenue
- $3.02 billion
- Full-year 2025 results from Feb 27, 2026 release
- 2025 GAAP net income
- $72 million
- Full-year 2025 results from Feb 27, 2026 release
- 2026 revenue guidance
- $3.05–3.15 billion
- Guidance provided on Feb 27, 2026
- 2026 adjusted EBITDA guidance
- $720–760 million
- Guidance provided on Feb 27, 2026
Previous Earnings date Reports
-
Set date and webcast details for Q4 and full-year 2025 results.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
BRIDGEWATER, N.J., April 07, 2026 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX) (“Amneal” or the “Company”), today announced that the Company will release its first quarter 2026 financial results on Friday, May 1, 2026, prior to market open. The Company will host an audio webcast at 8:30 a.m. ET.
The financial results and live webcast will be accessible through the Investor Relations section of the Company's website at https://investors.amneal.com. Individuals may register for the webcast by clicking the link here. To access the call through a conference line, dial 1 (833) 461-5787 (in the U.S.) or for a list of toll-free international numbers, visit this here. The access code for the call is 458312872. A replay of the conference call will be posted shortly after the call.
About Amneal
Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX), headquartered in Bridgewater, New Jersey, is a diversified, global biopharmaceutical leader focused on expanding access to affordable and innovative medicines. Founded in 2002 by brothers and co-CEOs Chirag and Chintu Patel, Amneal was built on the belief that innovation only matters if it’s accessible. Today, Amneal has a diverse and growing portfolio of approximately 300 complex, specialty and biosimilar medicines, delivering over 160 million prescriptions each year, primarily in the United States. Our Affordable Medicines segment spans retail, injectable, and biosimilar products. Our Specialty segment provides branded treatments in neurology, including Parkinson’s disease and migraine, and endocrinology. Our AvKARE segment distributes pharmaceuticals and medical products to U.S. federal, retail, and institutional customers. For more information, visit www.amneal.com and follow us on LinkedIn.
Investor Contact
Anthony DiMeo
VP, Investor Relations
anthony.dimeo@amneal.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.